(en) Núria Pujol-Moix, Angel Martinez-Perez, Maria Sabater-Lleal et Dolors Llobet, « Influence of ABO Locus on PFA-100 Collagen-ADP Closure Time Is Not Totally Dependent on the Von Willebrand Factor. Results of a GWAS on GAIT-2 Project Phenotypes », International Journal of Molecular Sciences, vol. 20, no 13, (ISSN1422-0067, PMID31262040, PMCID6651679, DOI10.3390/ijms20133221, lire en ligne, consulté le ).
Surbhi Saini, Ashley N. Folta, Katherine L. Harsh et Joseph R. Stanek, « Anti-Factor Xa-Based Monitoring of Unfractionated Heparin: Clinical Outcomes in a Pediatric Cohort », The Journal of Pediatrics, vol. 209, , p. 212–219.e1 (ISSN1097-6833, PMID30961988, DOI10.1016/j.jpeds.2019.02.015, lire en ligne, consulté le )
Dolly A. Parasrampuria et Kenneth E. Truitt, « Pharmacokinetics and Pharmacodynamics of Edoxaban, a Non-Vitamin K Antagonist Oral Anticoagulant that Inhibits Clotting Factor Xa », Clinical Pharmacokinetics, vol. 55, no 6, , p. 641–655 (ISSN1179-1926, PMID26620048, PMCID4875962, DOI10.1007/s40262-015-0342-7, lire en ligne, consulté le )
Aaron D. Shmookler, Ruta Arays et Paul McCarthy, « Inpatient management strategies in a severe case of heparin-induced thrombocytopenia », Transfusion and Apheresis Science: Official Journal of the World Apheresis Association: Official Journal of the European Society for Haemapheresis, (ISSN1473-0502, PMID31327731, DOI10.1016/j.transci.2019.06.030, lire en ligne, consulté le )
E. Gezelius, P. O. Bendahl, K. Gonçalves de Oliveira et L. Ek, « Low-molecular-weight heparin adherence and effects on survival within a randomised phase III lung cancer trial (RASTEN) », European Journal of Cancer (Oxford, England: 1990), vol. 118, , p. 82–90 (ISSN1879-0852, PMID31326730, DOI10.1016/j.ejca.2019.06.015, lire en ligne, consulté le )
Christopher S. D. Almond, James Harrington, Ravi Thiagarajan et Christine N. Duncan, « Successful use of bivalirudin for cardiac transplantation in a child with heparin-induced thrombocytopenia », The Journal of Heart and Lung Transplantation: The Official Publication of the International Society for Heart Transplantation, vol. 25, no 11, , p. 1376–1379 (ISSN1557-3117, PMID17097505, DOI10.1016/j.healun.2006.08.005, lire en ligne, consulté le )
Zev Davis, Richard Anderson, Daniel Short et David Garber, « Favorable outcome with bivalirudin anticoagulation during cardiopulmonary bypass », The Annals of Thoracic Surgery, vol. 75, no 1, , p. 264–265 (ISSN0003-4975, PMID12537226, DOI10.1016/s0003-4975(02)04299-6, lire en ligne, consulté le )
P. W. Armstrong et M. J. Mant, « Bleeding risks, risk factors and management of bleeding complications after treatment with anticoagulants, specific antithrombins, thrombolytics IIb-IIIa receptor blockers », European Heart Journal, vol. 16 Suppl L, , p. 75–80 (ISSN0195-668X, PMID8869023, DOI10.1093/eurheartj/16.suppl_l.75, lire en ligne, consulté le )
Abdullah S. Al Saleh, Patrick Berrigan, David Anderson et Sudeep Shivakumar, « Direct Oral Anticoagulants and Vitamin K Antagonists for Treatment of Deep Venous Thrombosis and Pulmonary Embolism in the Outpatient Setting: Comparative Economic Evaluation », The Canadian Journal of Hospital Pharmacy, vol. 70, no 3, , p. 188–199 (ISSN1920-2903, PMID28680172, PMCID5491194, DOI10.4212/cjhp.v70i3.1658, lire en ligne, consulté le )
Theodore E. Warkentin, Menaka Pai et Lori-Ann Linkins, « Direct oral anticoagulants for treatment of HIT: update of Hamilton experience and literature review », Blood, vol. 130, no 9, 08 31, 2017, p. 1104–1113 (ISSN1528-0020, PMID28646118, DOI10.1182/blood-2017-04-778993, lire en ligne, consulté le )
M. M. Samama et G. Gerotziafas, « Trois nouveaux anticoagulants disponibles en 2011: Dabigatran Etexilate, Rivaroxaban et Apixaban », Bio tribune magazine, vol. 38, no 1, , p. 10 (ISSN1951-655X, DOI10.1007/s11834-011-0048-6, lire en ligne, consulté le )
Michela Cini, Cristina Legnani, Sophie Testa et Armando Tripodi, « An in vitro study to investigate the interference of enoxaparin on plasma levels of direct oral factor Xa inhibitors measured by chromogenic assays », International Journal of Laboratory Hematology, vol. 41, no 3, , p. 309–315 (ISSN1751-553X, PMID30698331, PMCID6850445, DOI10.1111/ijlh.12974, lire en ligne, consulté le )
Bettina Kovács, Zsuzsanna Bereczky, Zsolt Oláh et Réka Gindele, « The superiority of anti-FXa assay over anti-FIIa assay in detecting heparin-binding site antithrombin deficiency », American Journal of Clinical Pathology, vol. 140, no 5, , p. 675–679 (ISSN1943-7722, PMID24124146, DOI10.1309/AJCPVY4Z9XZMFOTH, lire en ligne, consulté le )
M. M. Samama et G. Gerotziafas, « Trois nouveaux anticoagulants disponibles en 2011: Dabigatran Etexilate, Rivaroxaban et Apixaban », Bio tribune magazine, vol. 38, no 1, , p. 10 (ISSN1951-655X, DOI10.1007/s11834-011-0048-6, lire en ligne, consulté le )
Hollender L. F, « Eugène Koeberlé (1828-1915), père de la chirurgie moderne », /data/revues/00033944/v0126i06/01005612/, (lire en ligne, consulté le )
(en) A.G.N., « Thrombocytopenia as a manifestation of poisoning », Canadian Medical Association Journal, vol. 30, no 6, , p. 654–656 (ISSN0008-4409, PMID20319544, lire en ligne, consulté le ).
(en) Núria Pujol-Moix, Angel Martinez-Perez, Maria Sabater-Lleal et Dolors Llobet, « Influence of ABO Locus on PFA-100 Collagen-ADP Closure Time Is Not Totally Dependent on the Von Willebrand Factor. Results of a GWAS on GAIT-2 Project Phenotypes », International Journal of Molecular Sciences, vol. 20, no 13, (ISSN1422-0067, PMID31262040, PMCID6651679, DOI10.3390/ijms20133221, lire en ligne, consulté le ).
Eugene Ng et Amanda D. Loewy, « Document de principes : Lignes directrices sur la prophylaxie à la vitamine K chez les nouveau-nés », Canadian Family Physician, vol. 64, no 10, , e431–e434 (ISSN0008-350X, PMID30315032, PMCID6184950, lire en ligne, consulté le ).
F. Bilora, V. Boccioletti, E. Manfredini et F. Petrobelli, « Seasonal variation in the incidence of deep vein thrombosis in patients with deficiency of protein C or protein S », Clinical and Applied Thrombosis/Hemostasis: Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, vol. 8, no 3, , p. 231–237 (ISSN1076-0296, PMID12361200, lire en ligne, consulté le )
Surbhi Saini, Ashley N. Folta, Katherine L. Harsh et Joseph R. Stanek, « Anti-Factor Xa-Based Monitoring of Unfractionated Heparin: Clinical Outcomes in a Pediatric Cohort », The Journal of Pediatrics, vol. 209, , p. 212–219.e1 (ISSN1097-6833, PMID30961988, DOI10.1016/j.jpeds.2019.02.015, lire en ligne, consulté le )
Dolly A. Parasrampuria et Kenneth E. Truitt, « Pharmacokinetics and Pharmacodynamics of Edoxaban, a Non-Vitamin K Antagonist Oral Anticoagulant that Inhibits Clotting Factor Xa », Clinical Pharmacokinetics, vol. 55, no 6, , p. 641–655 (ISSN1179-1926, PMID26620048, PMCID4875962, DOI10.1007/s40262-015-0342-7, lire en ligne, consulté le )
J. Natali et J. F. Tricot, « The role of surgery in the treatment of acute phlebitis in the lower members », Phlebologie, vol. 35, no 1, , p. 187–201 (ISSN0031-8280, PMID7071170, lire en ligne, consulté le )
Aaron D. Shmookler, Ruta Arays et Paul McCarthy, « Inpatient management strategies in a severe case of heparin-induced thrombocytopenia », Transfusion and Apheresis Science: Official Journal of the World Apheresis Association: Official Journal of the European Society for Haemapheresis, (ISSN1473-0502, PMID31327731, DOI10.1016/j.transci.2019.06.030, lire en ligne, consulté le )
E. Gezelius, P. O. Bendahl, K. Gonçalves de Oliveira et L. Ek, « Low-molecular-weight heparin adherence and effects on survival within a randomised phase III lung cancer trial (RASTEN) », European Journal of Cancer (Oxford, England: 1990), vol. 118, , p. 82–90 (ISSN1879-0852, PMID31326730, DOI10.1016/j.ejca.2019.06.015, lire en ligne, consulté le )
Christopher S. D. Almond, James Harrington, Ravi Thiagarajan et Christine N. Duncan, « Successful use of bivalirudin for cardiac transplantation in a child with heparin-induced thrombocytopenia », The Journal of Heart and Lung Transplantation: The Official Publication of the International Society for Heart Transplantation, vol. 25, no 11, , p. 1376–1379 (ISSN1557-3117, PMID17097505, DOI10.1016/j.healun.2006.08.005, lire en ligne, consulté le )
Zev Davis, Richard Anderson, Daniel Short et David Garber, « Favorable outcome with bivalirudin anticoagulation during cardiopulmonary bypass », The Annals of Thoracic Surgery, vol. 75, no 1, , p. 264–265 (ISSN0003-4975, PMID12537226, DOI10.1016/s0003-4975(02)04299-6, lire en ligne, consulté le )
P. W. Armstrong et M. J. Mant, « Bleeding risks, risk factors and management of bleeding complications after treatment with anticoagulants, specific antithrombins, thrombolytics IIb-IIIa receptor blockers », European Heart Journal, vol. 16 Suppl L, , p. 75–80 (ISSN0195-668X, PMID8869023, DOI10.1093/eurheartj/16.suppl_l.75, lire en ligne, consulté le )
Abdullah S. Al Saleh, Patrick Berrigan, David Anderson et Sudeep Shivakumar, « Direct Oral Anticoagulants and Vitamin K Antagonists for Treatment of Deep Venous Thrombosis and Pulmonary Embolism in the Outpatient Setting: Comparative Economic Evaluation », The Canadian Journal of Hospital Pharmacy, vol. 70, no 3, , p. 188–199 (ISSN1920-2903, PMID28680172, PMCID5491194, DOI10.4212/cjhp.v70i3.1658, lire en ligne, consulté le )
(en) Carina E. Seculini Patiño et Aldo H. Tabares, « [Heparin-induced thrombocytopenia. New therapeutical options] », Medicina, vol. 76, no 4, , p. 230–234 (ISSN0025-7680, PMID27576282, lire en ligne, consulté le ).
Theodore E. Warkentin, Menaka Pai et Lori-Ann Linkins, « Direct oral anticoagulants for treatment of HIT: update of Hamilton experience and literature review », Blood, vol. 130, no 9, 08 31, 2017, p. 1104–1113 (ISSN1528-0020, PMID28646118, DOI10.1182/blood-2017-04-778993, lire en ligne, consulté le )
M. M. Samama et G. Gerotziafas, « Trois nouveaux anticoagulants disponibles en 2011: Dabigatran Etexilate, Rivaroxaban et Apixaban », Bio tribune magazine, vol. 38, no 1, , p. 10 (ISSN1951-655X, DOI10.1007/s11834-011-0048-6, lire en ligne, consulté le )
Michela Cini, Cristina Legnani, Sophie Testa et Armando Tripodi, « An in vitro study to investigate the interference of enoxaparin on plasma levels of direct oral factor Xa inhibitors measured by chromogenic assays », International Journal of Laboratory Hematology, vol. 41, no 3, , p. 309–315 (ISSN1751-553X, PMID30698331, PMCID6850445, DOI10.1111/ijlh.12974, lire en ligne, consulté le )
Benjamin Alouidor, Robin E. Sweeney, Trinny Tat et Raymond K. Wong, « Microfluidic Point-of-Care Ecarin-Based Clotting and Chromogenic Assays for Monitoring Direct Thrombin Inhibitors », The Journal of Extra-Corporeal Technology, vol. 51, no 1, , p. 29–37 (ISSN0022-1058, PMID30936586, PMCID6436170, lire en ligne, consulté le )
Bettina Kovács, Zsuzsanna Bereczky, Zsolt Oláh et Réka Gindele, « The superiority of anti-FXa assay over anti-FIIa assay in detecting heparin-binding site antithrombin deficiency », American Journal of Clinical Pathology, vol. 140, no 5, , p. 675–679 (ISSN1943-7722, PMID24124146, DOI10.1309/AJCPVY4Z9XZMFOTH, lire en ligne, consulté le )
(en) A.G.N., « Thrombocytopenia as a manifestation of poisoning », Canadian Medical Association Journal, vol. 30, no 6, , p. 654–656 (ISSN0008-4409, PMID20319544, lire en ligne, consulté le ).
(en) Núria Pujol-Moix, Angel Martinez-Perez, Maria Sabater-Lleal et Dolors Llobet, « Influence of ABO Locus on PFA-100 Collagen-ADP Closure Time Is Not Totally Dependent on the Von Willebrand Factor. Results of a GWAS on GAIT-2 Project Phenotypes », International Journal of Molecular Sciences, vol. 20, no 13, (ISSN1422-0067, PMID31262040, PMCID6651679, DOI10.3390/ijms20133221, lire en ligne, consulté le ).
Eugene Ng et Amanda D. Loewy, « Document de principes : Lignes directrices sur la prophylaxie à la vitamine K chez les nouveau-nés », Canadian Family Physician, vol. 64, no 10, , e431–e434 (ISSN0008-350X, PMID30315032, PMCID6184950, lire en ligne, consulté le ).
F. Bilora, V. Boccioletti, E. Manfredini et F. Petrobelli, « Seasonal variation in the incidence of deep vein thrombosis in patients with deficiency of protein C or protein S », Clinical and Applied Thrombosis/Hemostasis: Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, vol. 8, no 3, , p. 231–237 (ISSN1076-0296, PMID12361200, lire en ligne, consulté le )
Surbhi Saini, Ashley N. Folta, Katherine L. Harsh et Joseph R. Stanek, « Anti-Factor Xa-Based Monitoring of Unfractionated Heparin: Clinical Outcomes in a Pediatric Cohort », The Journal of Pediatrics, vol. 209, , p. 212–219.e1 (ISSN1097-6833, PMID30961988, DOI10.1016/j.jpeds.2019.02.015, lire en ligne, consulté le )
Dolly A. Parasrampuria et Kenneth E. Truitt, « Pharmacokinetics and Pharmacodynamics of Edoxaban, a Non-Vitamin K Antagonist Oral Anticoagulant that Inhibits Clotting Factor Xa », Clinical Pharmacokinetics, vol. 55, no 6, , p. 641–655 (ISSN1179-1926, PMID26620048, PMCID4875962, DOI10.1007/s40262-015-0342-7, lire en ligne, consulté le )
J. Natali et J. F. Tricot, « The role of surgery in the treatment of acute phlebitis in the lower members », Phlebologie, vol. 35, no 1, , p. 187–201 (ISSN0031-8280, PMID7071170, lire en ligne, consulté le )
Aaron D. Shmookler, Ruta Arays et Paul McCarthy, « Inpatient management strategies in a severe case of heparin-induced thrombocytopenia », Transfusion and Apheresis Science: Official Journal of the World Apheresis Association: Official Journal of the European Society for Haemapheresis, (ISSN1473-0502, PMID31327731, DOI10.1016/j.transci.2019.06.030, lire en ligne, consulté le )
E. Gezelius, P. O. Bendahl, K. Gonçalves de Oliveira et L. Ek, « Low-molecular-weight heparin adherence and effects on survival within a randomised phase III lung cancer trial (RASTEN) », European Journal of Cancer (Oxford, England: 1990), vol. 118, , p. 82–90 (ISSN1879-0852, PMID31326730, DOI10.1016/j.ejca.2019.06.015, lire en ligne, consulté le )
Christopher S. D. Almond, James Harrington, Ravi Thiagarajan et Christine N. Duncan, « Successful use of bivalirudin for cardiac transplantation in a child with heparin-induced thrombocytopenia », The Journal of Heart and Lung Transplantation: The Official Publication of the International Society for Heart Transplantation, vol. 25, no 11, , p. 1376–1379 (ISSN1557-3117, PMID17097505, DOI10.1016/j.healun.2006.08.005, lire en ligne, consulté le )
Zev Davis, Richard Anderson, Daniel Short et David Garber, « Favorable outcome with bivalirudin anticoagulation during cardiopulmonary bypass », The Annals of Thoracic Surgery, vol. 75, no 1, , p. 264–265 (ISSN0003-4975, PMID12537226, DOI10.1016/s0003-4975(02)04299-6, lire en ligne, consulté le )
P. W. Armstrong et M. J. Mant, « Bleeding risks, risk factors and management of bleeding complications after treatment with anticoagulants, specific antithrombins, thrombolytics IIb-IIIa receptor blockers », European Heart Journal, vol. 16 Suppl L, , p. 75–80 (ISSN0195-668X, PMID8869023, DOI10.1093/eurheartj/16.suppl_l.75, lire en ligne, consulté le )
Abdullah S. Al Saleh, Patrick Berrigan, David Anderson et Sudeep Shivakumar, « Direct Oral Anticoagulants and Vitamin K Antagonists for Treatment of Deep Venous Thrombosis and Pulmonary Embolism in the Outpatient Setting: Comparative Economic Evaluation », The Canadian Journal of Hospital Pharmacy, vol. 70, no 3, , p. 188–199 (ISSN1920-2903, PMID28680172, PMCID5491194, DOI10.4212/cjhp.v70i3.1658, lire en ligne, consulté le )
(en) Carina E. Seculini Patiño et Aldo H. Tabares, « [Heparin-induced thrombocytopenia. New therapeutical options] », Medicina, vol. 76, no 4, , p. 230–234 (ISSN0025-7680, PMID27576282, lire en ligne, consulté le ).
Theodore E. Warkentin, Menaka Pai et Lori-Ann Linkins, « Direct oral anticoagulants for treatment of HIT: update of Hamilton experience and literature review », Blood, vol. 130, no 9, 08 31, 2017, p. 1104–1113 (ISSN1528-0020, PMID28646118, DOI10.1182/blood-2017-04-778993, lire en ligne, consulté le )
Michela Cini, Cristina Legnani, Sophie Testa et Armando Tripodi, « An in vitro study to investigate the interference of enoxaparin on plasma levels of direct oral factor Xa inhibitors measured by chromogenic assays », International Journal of Laboratory Hematology, vol. 41, no 3, , p. 309–315 (ISSN1751-553X, PMID30698331, PMCID6850445, DOI10.1111/ijlh.12974, lire en ligne, consulté le )
Benjamin Alouidor, Robin E. Sweeney, Trinny Tat et Raymond K. Wong, « Microfluidic Point-of-Care Ecarin-Based Clotting and Chromogenic Assays for Monitoring Direct Thrombin Inhibitors », The Journal of Extra-Corporeal Technology, vol. 51, no 1, , p. 29–37 (ISSN0022-1058, PMID30936586, PMCID6436170, lire en ligne, consulté le )
Bettina Kovács, Zsuzsanna Bereczky, Zsolt Oláh et Réka Gindele, « The superiority of anti-FXa assay over anti-FIIa assay in detecting heparin-binding site antithrombin deficiency », American Journal of Clinical Pathology, vol. 140, no 5, , p. 675–679 (ISSN1943-7722, PMID24124146, DOI10.1309/AJCPVY4Z9XZMFOTH, lire en ligne, consulté le )
(en) Frantz VK, « Hemostasis With Absorbable Gauze (Oxidized Cellulose) », ANNALS OF SURGERY - A Monthly Review Of Surgical Science since 1985, 1944-aug, p. 181-198 (lire en ligne).
Dolly A. Parasrampuria et Kenneth E. Truitt, « Pharmacokinetics and Pharmacodynamics of Edoxaban, a Non-Vitamin K Antagonist Oral Anticoagulant that Inhibits Clotting Factor Xa », Clinical Pharmacokinetics, vol. 55, no 6, , p. 641–655 (ISSN1179-1926, PMID26620048, PMCID4875962, DOI10.1007/s40262-015-0342-7, lire en ligne, consulté le )